Kimberly Lockwood Power - 01 Jun 2026 Form 3/A - Amendment Insider Report for CONMED Corp (CNMD)

Reporting relationship
Interim Corp Controller & PAO
Issuer ticker
CNMD
Reported as of
01 Jun 2026
Net transaction value
$0
Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
3/A - Amendment
Accepted by SEC
03 Jun 2026, 12:30:15 UTC
Original report date
03 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Thomas Fistek for Kimberly Lockwood by Power of Attorney

Key filing fact

Kimberly Lockwood Power filed Form 3/A - Amendment for CONMED Corp (CNMD) on 03 Jun 2026.

Key facts

  • This page summarizes Kimberly Lockwood Power's Form 3/A - Amendment filing for CONMED Corp (CNMD).
  • 0 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 03 Jun 2026, 12:30.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.

View source filing

Reporting Owners (1)

CIK 0002136158 Primary reporting owner

Lockwood Kimberly

Relationship
Interim Corp Controller & PAO
Address
C/O CONMED CORPORATION, 11311 CONCEPT BOULEVARD, LARGO
Signature
/s/ Thomas Fistek for Kimberly Lockwood by Power of Attorney
Signature date
03 Jun 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CNMD holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,868
Date
01 Jun 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CNMD holding Derivative

Options To Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,400
Exercise price
$59.96
Footnotes
F1
CNMD holding Derivative

Options To Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,200
Exercise price
$78.76
Footnotes
F2
CNMD holding Derivative

Options To Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
3,500
Exercise price
$97.69
Footnotes
F2
CNMD holding Derivative

Options To Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,750
Exercise price
$144.55
Footnotes
F2
CNMD holding Derivative

Options To Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,500
Exercise price
$96.16
Footnotes
F2
CNMD holding Derivative

Options To Purchase Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,500
Exercise price
$58.33
Footnotes
F2
CNMD holding Derivative

RSUs (Restricted Stock Units)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,839
Exercise price
$0.000000
Footnotes
F3
CNMD holding Derivative

RSUs (Restricted Stock Units)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date
01 Jun 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,838
Exercise price
$0.000000
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Footnote F2

The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

Footnote F3

Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

SEC remarks

This Form 3/A is filed solely to correct the officer title which was incorrect in the initial filing.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .